NO20044050L - Fremgangsmate for syntese av chirale N-aryl-piperaziner - Google Patents
Fremgangsmate for syntese av chirale N-aryl-piperazinerInfo
- Publication number
- NO20044050L NO20044050L NO20044050A NO20044050A NO20044050L NO 20044050 L NO20044050 L NO 20044050L NO 20044050 A NO20044050 A NO 20044050A NO 20044050 A NO20044050 A NO 20044050A NO 20044050 L NO20044050 L NO 20044050L
- Authority
- NO
- Norway
- Prior art keywords
- piperazines
- chiral
- aryl
- synthesis
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36343102P | 2002-03-12 | 2002-03-12 | |
| PCT/US2003/007078 WO2003078417A1 (en) | 2002-03-12 | 2003-03-10 | Process for synthesizing chiral n-aryl piperazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20044050L true NO20044050L (no) | 2004-09-24 |
Family
ID=28041762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20044050A NO20044050L (no) | 2002-03-12 | 2004-09-24 | Fremgangsmate for syntese av chirale N-aryl-piperaziner |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6713626B2 (no) |
| EP (1) | EP1483255B1 (no) |
| JP (1) | JP4391241B2 (no) |
| KR (1) | KR20040105765A (no) |
| CN (2) | CN1304388C (no) |
| AR (1) | AR038930A1 (no) |
| AT (1) | ATE439356T1 (no) |
| AU (1) | AU2003220094B2 (no) |
| BR (1) | BR0308377A (no) |
| CA (1) | CA2477892C (no) |
| CR (1) | CR7431A (no) |
| DE (1) | DE60328756D1 (no) |
| EC (1) | ECSP045290A (no) |
| ES (1) | ES2329122T3 (no) |
| IL (1) | IL163827A0 (no) |
| MX (1) | MXPA04008729A (no) |
| NO (1) | NO20044050L (no) |
| NZ (1) | NZ535168A (no) |
| RU (1) | RU2315762C2 (no) |
| TW (1) | TW200403231A (no) |
| UA (1) | UA79273C2 (no) |
| WO (1) | WO2003078417A1 (no) |
| ZA (1) | ZA200408202B (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060223824A1 (en) | 2000-11-28 | 2006-10-05 | Wyeth | Serotonergic agents |
| US20060287335A1 (en) * | 2000-11-28 | 2006-12-21 | Wyeth | Serotonergic agents for treating sexual dysfunction |
| WO2003007956A1 (en) * | 2001-07-20 | 2003-01-30 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
| KR20040091119A (ko) * | 2002-03-12 | 2004-10-27 | 와이어쓰 | 키랄 1,4-이치환된 피페라진의 제조방법 |
| US7091349B2 (en) * | 2002-03-12 | 2006-08-15 | Wyeth | Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution |
| US7361773B2 (en) | 2002-03-12 | 2008-04-22 | Wyeth | Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| AU2003220122A1 (en) * | 2002-03-12 | 2003-09-29 | Wyeth | Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| PA8626301A1 (es) * | 2004-03-19 | 2006-12-07 | Wyeth Wyeth | Proceso para preparar derivados de n-aril-piperazina |
| US20050215561A1 (en) * | 2004-03-19 | 2005-09-29 | Krishnendu Ghosh | Pharmaceutical dosage forms and compositions |
| US20070099931A1 (en) * | 2004-03-19 | 2007-05-03 | Wyeth | Pharmaceutical dosage forms and compositions |
| CN101137648A (zh) * | 2005-03-01 | 2008-03-05 | 惠氏公司 | 结晶和非晶4－氰基－n－{(2r)－2－[4－(2,3－二氢－苯并[1,4]二氧杂环己烯－5－基)－哌嗪－1－基]－丙基}－n－吡啶－2－基－苯甲酰胺盐酸盐 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0189612B1 (en) | 1984-12-21 | 1992-11-04 | Duphar International Research B.V | New pharmaceutical compositions having a psychotropic activity |
| JPH01125357A (ja) | 1987-11-06 | 1989-05-17 | Dainippon Pharmaceut Co Ltd | トリペプチドの誘導体 |
| IL101722A (en) * | 1991-05-02 | 1996-05-14 | Wyeth John & Brother Ltd | History of piperazine, their preparation and pharmaceutical preparations containing them |
| WO1994024115A1 (en) * | 1993-04-16 | 1994-10-27 | Santen Pharmaceutical Co., Ltd. | Novel piperazine derivative |
| GB9411099D0 (en) * | 1994-06-03 | 1994-07-27 | Wyeth John & Brother Ltd | Piperazine derivatives |
| WO1995033725A1 (en) | 1994-06-03 | 1995-12-14 | John Wyeth & Brother Limited | Novel processes and intermediates for the preparation of piperazine derivatives |
| GB9413772D0 (en) * | 1994-07-08 | 1994-08-24 | Wyeth John & Brother Ltd | 5-HT1A ligands |
| GB9514901D0 (en) * | 1995-07-20 | 1995-09-20 | American Home Prod | Piperazine derivatives |
| DE69716900T2 (de) | 1996-04-10 | 2003-07-03 | Merck & Co., Inc. | Alpha v Beta 3 ANTAGONISTEN |
| US6469007B2 (en) | 2000-11-28 | 2002-10-22 | Wyeth | Serotonergic agents |
-
2003
- 2003-03-10 WO PCT/US2003/007078 patent/WO2003078417A1/en active Application Filing
- 2003-03-10 NZ NZ535168A patent/NZ535168A/xx unknown
- 2003-03-10 US US10/384,845 patent/US6713626B2/en not_active Expired - Fee Related
- 2003-03-10 TW TW092105097A patent/TW200403231A/zh unknown
- 2003-03-10 MX MXPA04008729A patent/MXPA04008729A/es active IP Right Grant
- 2003-03-10 KR KR10-2004-7014156A patent/KR20040105765A/ko not_active Application Discontinuation
- 2003-03-10 CA CA2477892A patent/CA2477892C/en not_active Expired - Fee Related
- 2003-03-10 JP JP2003576423A patent/JP4391241B2/ja not_active Expired - Fee Related
- 2003-03-10 CN CNB038058413A patent/CN1304388C/zh not_active Expired - Fee Related
- 2003-03-10 CN CNA2007100083292A patent/CN1982307A/zh active Pending
- 2003-03-10 BR BR0308377-2A patent/BR0308377A/pt not_active IP Right Cessation
- 2003-03-10 IL IL16382703A patent/IL163827A0/xx unknown
- 2003-03-10 EP EP03716384A patent/EP1483255B1/en not_active Expired - Lifetime
- 2003-03-10 DE DE60328756T patent/DE60328756D1/de not_active Expired - Lifetime
- 2003-03-10 AU AU2003220094A patent/AU2003220094B2/en not_active Expired - Fee Related
- 2003-03-10 ES ES03716384T patent/ES2329122T3/es not_active Expired - Lifetime
- 2003-03-10 RU RU2004130300/04A patent/RU2315762C2/ru not_active IP Right Cessation
- 2003-03-10 AT AT03716384T patent/ATE439356T1/de not_active IP Right Cessation
- 2003-03-11 AR ARP030100831A patent/AR038930A1/es unknown
- 2003-10-03 UA UA20041008211A patent/UA79273C2/uk unknown
-
2004
- 2004-08-24 CR CR7431A patent/CR7431A/es not_active Application Discontinuation
- 2004-09-10 EC EC2004005290A patent/ECSP045290A/es unknown
- 2004-09-24 NO NO20044050A patent/NO20044050L/no not_active Application Discontinuation
- 2004-10-11 ZA ZA200408202A patent/ZA200408202B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04008729A (es) | 2005-07-13 |
| CA2477892C (en) | 2010-11-23 |
| AR038930A1 (es) | 2005-02-02 |
| ECSP045290A (es) | 2004-10-26 |
| KR20040105765A (ko) | 2004-12-16 |
| CR7431A (es) | 2008-07-29 |
| US20030187265A1 (en) | 2003-10-02 |
| ES2329122T3 (es) | 2009-11-23 |
| JP4391241B2 (ja) | 2009-12-24 |
| JP2005526775A (ja) | 2005-09-08 |
| EP1483255A1 (en) | 2004-12-08 |
| IL163827A0 (en) | 2005-12-18 |
| CA2477892A1 (en) | 2003-09-25 |
| US6713626B2 (en) | 2004-03-30 |
| BR0308377A (pt) | 2005-01-11 |
| EP1483255B1 (en) | 2009-08-12 |
| CN1642936A (zh) | 2005-07-20 |
| UA79273C2 (en) | 2007-06-11 |
| AU2003220094A1 (en) | 2003-09-29 |
| TW200403231A (en) | 2004-03-01 |
| RU2315762C2 (ru) | 2008-01-27 |
| DE60328756D1 (de) | 2009-09-24 |
| RU2004130300A (ru) | 2005-04-10 |
| NZ535168A (en) | 2006-03-31 |
| CN1982307A (zh) | 2007-06-20 |
| WO2003078417A1 (en) | 2003-09-25 |
| ATE439356T1 (de) | 2009-08-15 |
| AU2003220094B2 (en) | 2009-04-23 |
| CN1304388C (zh) | 2007-03-14 |
| ZA200408202B (en) | 2007-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043345L (no) | Fremgangsmate for fremstilling av hydrokarboner | |
| NO20034285D0 (no) | Fremgangsmåte for fremstilling av syntesegass | |
| CY2015015I1 (el) | Παραγωγη τιακουμυκινης | |
| NO20053796D0 (no) | Process for the production of particles | |
| IS7834A (is) | Aðferð til nýmyndunar á bensímídasólefnasambandi | |
| HRP20050360A2 (en) | Novel method for the industrial synthesis of the m | |
| NO20043586L (no) | Fremgangsmate for fremstilling av organiske forbindelser | |
| NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
| NO20041182L (no) | Fremgangsmate for fremstilling av silisium | |
| ZA200602149B (en) | Process for the synthesis of 6-amino-4-[(3-chloro-4-fluo-rophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile | |
| NO20033408D0 (no) | Fremgangsmåte for fremstilling av krystallinske nanopartikler | |
| NO20044050L (no) | Fremgangsmate for syntese av chirale N-aryl-piperaziner | |
| NO20050885L (no) | Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| NO20041850L (no) | Fremgangsmate for dannelse av profenkrystaller | |
| NO20041224L (no) | Fremgangsmate for fremstilling av hydrokarboner | |
| NO20034597L (no) | Fremgangsmate for fremstilling av cantaxantin | |
| ITMI20020933A0 (it) | Procedimento per la sintesi di clopidogrel | |
| NO20043760L (no) | Fremgangsmate til fremstilling av olefiner | |
| NO20043988L (no) | Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner | |
| DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
| AU2003242867A8 (en) | Process for the synthesis of mosapride | |
| NO20052392L (no) | Fremgangsmate for fremstilling av acetylenforbindelser. | |
| NO20052396D0 (no) | Fremgangsmate for fremstilling av spirolactonforbindelser | |
| EG24122A (en) | Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines | |
| ITMI20020934A0 (it) | Processo per la sintesi di benazepril cloridrato |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |